Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2008 09:05 ET | Source: Barrier Therapeutics, Inc.

Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.

PRINCETON, N.J., Aug. 5, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, announced...
July 29, 2008 09:23 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc.

PRINCETON, N.J., July 29, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today...
June 23, 2008 09:00 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement

PRINCETON, N.J., June 23, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today...
May 22, 2008 07:30 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo

PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology,...
April 29, 2008 16:00 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics Announces First Quarter 2008 Financial Results

PRINCETON, N.J., April 29, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced its financial...
April 28, 2008 07:30 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics to Present At the Deutsche Bank 33rd Annual Health Care Conference

PRINCETON, N.J., April 28, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive...
April 22, 2008 07:39 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics to Release First Quarter 2008 Financial Results on April 29, 2008

PRINCETON, N.J., April 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, will release...
April 09, 2008 07:20 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics Announces Positive Results in Reducing Itch Symptoms With Novel Oral Antihistamine Agent Hivenyl

PRINCETON, N.J., April 9, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today...
March 24, 2008 13:04 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics Granted Second Interim Patent Term Extension for Vusion Ointment

PRINCETON, N.J., March 24, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, announced...
March 17, 2008 16:30 ET | Source: Barrier Therapeutics, Inc.

Barrier Therapeutics Announces Chief Financial Officer Succession

PRINCETON, N.J., March 17, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX) announced today that Dennis P. Reilly, Vice President of Finance and Principal Accounting Officer of the...